Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Kinnevik AB
  6. News
  7. Summary
    KINV B   SE0015810247


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Kinnevik : Invests USD 100 Million in Spring Health, a Leading Global Mental Health Solution

09/16/2021 | 09:09am EST

Kinnevik AB (publ) ("Kinnevik”) today announced that it is investing USD 100m in Spring Health, a leading global mental health solution.

Spring Health helps employers modernise their behavioral health benefits with the most comprehensive solution for employee mental well-being.  The company was founded by April Koh and Dr Adam Chekroud in New York with the vision to build a world where guessing has no place in mental healthcare. All too often, patients must undergo a trial-and-error approach to finding effective and efficient mental healthcare. Spring Health is building the data infrastructure to make more precise decisions when it comes to provider matching and the creation of personalized care plans. Recent data has revealed that this approach delivers best-in-class outcomes in half the time as others in the industry. Spring Health provides a single point of contact for any type of support — from digital exercises to employee assistance program (EAP) services, to coaching, therapy, or medication — leading to faster outcomes, higher engagement, and healthier, happier employees and their families. Today, Spring Health serves over 150 companies, from start-ups to multinational Fortune 500 corporations.

Georgi Ganev, CEO of Kinnevik commented: “We are incredibly excited to support Spring Health and its founders April and Adam in this next chapter. We believe Spring Health’s distinct and innovative approach to mental healthcare will set a new standard in the space and establish the company as a long-term market leader. The investment builds on our continued momentum in US and global healthcare innovation.”

Kinnevik led the USD 190m round with an investment of USD 100m for a 5 percent stake joined by new investor The Guardian Life Insurance Company of America (Guardian Life) and along with existing investors including Tiger Global and Northzone. Spring Health’s total capital raised is to date is USD 300 million. The latest round brings the company’s valuation to USD 2 billion, on the heels of approximately 6x revenue growth over the past year.

For further information, visit www.kinnevik.com or contact:

Torun Litzén, Director Investor Relations
Phone +46 (0)70 762 00 50
Email press@kinnevik.com

Kinnevik’s ambition is to be Europe’s leading listed growth investor, and we back the best digital companies for a reimagined everyday and to deliver significant returns. We understand complex and fast-changing consumer behaviours, and have a strong and expanding portfolio in healthtech, consumer services, foodtech and fintech. As a long-term investor, we strongly believe that investing in sustainable business models and diverse teams will bring the greatest returns for shareholders. We back our companies at every stage of their journey and invest in Europe, with a focus on the Nordics, and in the US. Kinnevik was founded in 1936 by the Stenbeck, Klingspor and von Horn families. Kinnevik’s shares are listed on Nasdaq Stockholm’s list for large cap companies under the ticker codes KINV A and KINV B.


  • Press release pdf

© OMX, source GlobeNewswire - EU Press Releases

All news about KINNEVIK AB
12/01Kinnevik Invests USD 115 Million in Jobandtalent, the World's Leading Digital Temp Staf..
11/30Increased Number of Shares and Votes in Kinnevik
11/16Kinnevik has issued SEK 2.0 billion in new sustainability-linked bonds
11/12Tele2 Nomination Committee Convened
11/02Kinnevik Publishes Sustainability Linked Financing Framework and Announces Intention to..
11/01KINNEVIK : Issue and Repurchase of Incentive Shares in Classes C 2021 and D 2021
10/28Luthman Backlund Foods Ab announced that it has received $100 million in funding from G..
10/22KINNEVIK : Investee Babylon Starts Trading in New York
10/21KINNEVIK : Babylon Closes Business Combination and Will Begin Trading on the New York Stoc..
10/21KINNEVIK : Extraordinary General Meeting 2021
More news
Analyst Recommendations on KINNEVIK AB
More recommendations
Sales 2021 1 502 M 166 M 166 M
Net income 2021 15 329 M 1 694 M 1 694 M
Net cash 2021 1 829 M 202 M 202 M
P/E ratio 2021 5,92x
Yield 2021 1,51%
Capitalization 91 697 M 10 139 M 10 132 M
EV / Sales 2021 59,8x
EV / Sales 2022 73,8x
Nbr of Employees 40
Free-Float 89,4%
Duration : Period :
Kinnevik AB Technical Analysis Chart | KINV B | SE0015810247 | MarketScreener
Technical analysis trends KINNEVIK AB
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus HOLD
Number of Analysts 8
Last Close Price 327,00 SEK
Average target price 322,17 SEK
Spread / Average Target -1,48%
EPS Revisions
Managers and Directors
Georgi Martin Ganev Chief Executive Officer
Erika Johanna Söderberg Johnson Chief Financial Officer
James Kennedy Anderson Chairman
Natalie Patricia Tydeman Senior Director-Investment
Lena Charlotte Strömberg Independent Director
Sector and Competitors
1st jan.Capi. (M$)
KINNEVIK AB59.45%10 287
INVESTOR AB (PUBL)47.48%73 277
HAL TRUST23.80%13 999